Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-07-12
1996-03-05
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 7, 514 11, 514 21, 540463, 540524, 540531, A61A 3805
Patent
active
054968054
ABSTRACT:
Diuresis, natriuresis, and the lowering of blood pressure are produced in a host by administering one or more neutral endopeptidase inhibitors. An additional blood pressure lowering agent such as an angiotensin converting enzyme inhibitor can be administered along with the neutral endopeptidase inhibitor.
REFERENCES:
patent: 4053651 (1977-10-01), Ondetti et al.
patent: 4105789 (1978-08-01), Ondetti et al.
patent: 4235885 (1980-11-01), Sundeen et al.
patent: 4316896 (1982-02-01), Thorsett et al.
patent: 4339600 (1982-07-01), Ondetti et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4379146 (1983-04-01), Greenlee et al.
patent: 4382081 (1983-05-01), Sundeen et al.
patent: 4401677 (1983-08-01), Greenberg et al.
patent: 4409146 (1983-10-01), Thorsett et al.
patent: 4423242 (1983-12-01), Wilkinson et al.
patent: 4432972 (1984-02-01), Karanewsky et al.
patent: 4452791 (1984-06-01), Ryono et al.
patent: 4495176 (1985-01-01), Brule et al.
patent: 4499079 (1985-02-01), Gordon et al.
patent: 4508712 (1985-04-01), Needleman
patent: 4587238 (1986-05-01), Harris et al.
patent: 4629787 (1986-12-01), Harris et al.
patent: 4722810 (1988-02-01), Delaney et al.
Cushman, Do Wo, et al., "Angiotensin-Converting Enzyme Inhibitors", Enzyme Inhibitors as Drugs, pp. 231-247, 1980.
Materson, "Advances in the Management of Hypertension:ACE Inhibitor Therapy", Cardiovascular Medicine, vol. 7, No. 9, Sep. 1986, pp. 175-191.
Vidt et al., "Captopril", The New England Journal of Medicine, vol. 306, No. 4, pp. 214-218 (1982).
Physician's Desk Reference, 1989 Edition, pp. 1408-1410 and 2080-2085.
Marsh et al., "Renal and Blood Pressure Response to Synthetic Atrial Natriuretic Factor . . . ", Hypertension, vol. 7, No. 3, 1985, pp. 386-391.
Seymour et al., "Synthetic Atrial Natriuretic Factor In Conscious Normotensive and Hypertensive Rats", Supp 1 Hypertension, vol. 7, No. 3, 1985, pp. I-35 to I-42.
Cushman et al., "Design of Potent Competitive Inhibitors . . . ", Biochemistry, vol. 16, No. 25, pp. 5484-5491 (1977).
Mumford et al., "Inhibition of Porcine Kidney Enkephalinase . . . ", Biochem & Biophys. Res. Comm., vol. 109, No. 4, pp. 1303-1309 (1982).
Elliott et al., "Synthesis and Biological Evaluation . . . " J. Med. Chem., vol. 28, pp. 1208-1216 (1985).
International Dictionary of Medicine And Biology, pp. 158, 163, 847, 1876 (1986).
Cushman David W.
DeForrest Jack M.
Delaney Norma G.
Gordon Eric M.
Davis Stephen B.
E. R. Squibb & Sons Inc.
Schain Howard E.
LandOfFree
Inhibitors of neutral endopeptidase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of neutral endopeptidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of neutral endopeptidase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1413024